Clindamycin as an Antimalarial Drug: Review of Clinical Trials
Year: 2002
Type: review
Abstract: Clinical trials from the 1970s and 1980s have shown the efficacy, safety, and practicability of the treatment of Plasmo-dium falciparum malaria with clindamycin. Two reviews from the early 1990s have summarized these studies in detail (24, 25). Since then, interest in clindamycin as an antimalarial has renewed and a number of recent clinical trials have evaluated clindamycin, both alone and as a partner in a combination, as a treatment for malaria. This minireview summarizes the data on the drug, with spe-cial attention given to developments during the last 10 years. Since no studies with animals and few in vitro studies have been published since publication of the last review, this mini-review will concentrate on human clinical trials. PROPERTIES OF CLINDAMYCIN Clindamycin (7-chloro-lincomycin) is a semisynthetic deriv-
Authors: Bertrand Lell, Peter G. Kremsner
Institutions: Albert Schweitzer Hospital, University of Tübingen
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2154759292
